Journal article
GM-CSF Transgene-Based Adjuvant Allows the Establishment of Protective Mucosal Immunity Following Vaccination with Inactivated Chlamydia trachomatis
Abstract
Cellular and humoral immune responses induced following murine Chlamydia trachomatis infection confer almost sterile protection against homologous reinfection. On the other hand, immunization with inactivated organism induces little protective immunity in this model system. The underlying mechanism(s) that determines such divergent outcome remains unclear, but elucidating the mechanism will probably be important for chlamydial vaccine …
Authors
Lu H; Xing Z; Brunham RC
Journal
The Journal of Immunology, Vol. 169, No. 11, pp. 6324–6331
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2002
DOI
10.4049/jimmunol.169.11.6324
ISSN
0022-1767
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Adenoviruses, HumanAdjuvants, ImmunologicAdministration, IntranasalAnimalsBacterial VaccinesChlamydia InfectionsChlamydia trachomatisFemaleGenetic VectorsGranulocyte-Macrophage Colony-Stimulating FactorImmunity, MucosalMiceMice, Inbred BALB CMice, TransgenicRecombinant ProteinsTransfectionVaccinationVaccines, Inactivated